600511.SH
China National Medicines Co., Ltd.
SSE · Healthcare · Medical - Distribution · CN
CNY 27.70
−0.36%Oct 20, 2026, 08:34 UTC
China National Pharmaceutical Group Corporation reported revenue of 40.606 billion yuan and attributable net profit of 1.476 billion yuan for the first three quarters of 2026.
Source:Oct 20, 2026, 08:34 UTC
China National Pharmaceutical Group Corporation reported third-quarter 2026 revenue of 13.878 billion yuan, up 0.95% year over year, and attributable net profit of 596 million yuan, up 9.70%.
Source:Aug 19, 2026, 08:40 UTC
China National Medicines Corporation Ltd reported its first-half 2026 results: revenue of 26.728 billion yuan, up 4.27% year-on-year; net profit attributable to shareholders of 880 million yuan, down 7.25% year-on-year.
Source: